NHS National Pharmaceuticals - Everolimus and terminated agreement products
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as po...
Buyer
NHS England
Value
£4,516,089
Published
20 Oct 2021
Closes
26 Apr 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
14 May 2021
Contract ends
1 Mar 2022
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Pharmaceuticals - Everolimus and terminated agreement products
£4,516,089
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the fr...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
20 Oct 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Document
Parties appointed to the Framework Agreement & SME status
Not provided
Parties appointed to the Framework Agreement & SME status
Document
Transparency Award Schedules
Not provided
Transparency Award Schedules
Document
Contains public sector information licensed under the Open Government Licence v3.0.